121(top 5%)
PR articles
3.9K(top 5%)
PR citations
34(top 5%)
PR h-index
37(top 5%)
h-index
145
documents
5.5K
doc citations
1.6K
citing journals
100
times ranked

Publications

133 peer-reviewed articles • 4,984 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases
Communications Biology, 2025, 8,
4.46Citations (PDF)
2Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study
Circulation, 2025, 151, 334-336
18.19Citations (PDF)
3A Beneficial Role for Gluteofemoral Adipose Tissue in Cerebrovascular Disease
Neurology, 2025, 104,
1.08Citations (PDF)
4Genetic Risk Scores in Stroke Research and Care
Stroke, 2025, 56, 2327-2336
6.02Citations (PDF)
5Single-cell transcriptome-wide Mendelian randomization and colocalization analyses uncover cell-specific mechanisms in atherosclerotic cardiovascular disease
American Journal of Human Genetics, 2025, 112, 1597-1609
6.512Citations (PDF)
6Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study
Circulation Genomic and Precision Medicine, 2025, 18,
2.94Citations (PDF)
7Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study
Lancet Regional Health - Europe, The, 2025, 56, 101428
7.04Citations (PDF)
8Genetic variation supports a causal role for valproate in prevention of ischemic stroke
International Journal of Stroke, 2024, 19, 84-93
6.55Citations (PDF)
9Deep Resequencing of the 1q22 Locus in Non‐Lobar Intracerebral Hemorrhage
Annals of Neurology, 2024, 95, 325-337
6.63Citations (PDF)
10Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis
The Lancet Healthy Longevity, 2024, 5, e31-e44
10.322Citations (PDF)
11Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis
Circulation, 2024, 149, 669-683
18.144Citations (PDF)
12Mendelian Randomization Applied to Neurology
Neurology, 2024, 102,
1.042Citations (PDF)
13Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis
The Lancet Healthy Longevity, 2024, 5, e31-e44
10.3100Citations (PDF)
14High‐Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke—Results of the DEMDAS Study
Journal of the American Heart Association, 2024, 13,
4.07Citations (PDF)
15Genetically proxied HTRA1 protease activity and circulating levels independently predict risk of ischemic stroke and coronary artery disease
Nature Cardiovascular Research, 2024, 3, 701-713
8.410Citations (PDF)
16DNA-sensing inflammasomes cause recurrent atherosclerotic stroke
Nature, 2024, 633, 433-441
38.084Citations (PDF)
17Genetically proxied IL‐6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study
Alzheimer's and Dementia: Translational Research and Clinical Interventions, 2024, 10,
4.84Citations (PDF)
18Risk factors and clinical significance of post‐stroke incident ischemic lesions
Alzheimer's and Dementia, 2024, 20, 8412-8428
0.510Citations (PDF)
19Association of Pressure Wave Reflections With Left Ventricular Mass: a Systematic Review and Meta-Analysis
Hypertension, 2023, 80,
6.610Citations (PDF)
20Genetic Risk Score Improves Risk Stratification for Anticoagulation-Related Intracerebral Hemorrhage
Stroke, 2023, 54, 791-799
6.06Citations (PDF)
21Soluble adhesion molecules and functional outcome after ischemic stroke: A Mendelian randomization study
Journal of Stroke and Cerebrovascular Diseases, 2023, 32, 107136
1.610Citations (PDF)
22A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage
Stroke, 2023, 54, 973-982
6.010Citations (PDF)
23Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke
Stroke, 2023, 54, 938-946
6.034Citations (PDF)
24Genetically Proxied CRP (C-Reactive Protein) Levels and Lobar Intracerebral Hemorrhage Risk
Stroke, 2023, 54,
6.07Citations (PDF)
25The Impact of Genetically Proxied AMPK Activation, the Target of Metformin, on Functional Outcome Following Ischemic Stroke
Journal of Stroke, 2023, 25, 266-271
4.78Citations (PDF)
26Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study
Frontiers in Immunology, 2023, 14,
4.921Citations (PDF)
27Interplay Between Chronic Kidney Disease, Hypertension, and Stroke
Neurology, 2023, 101,
1.034Citations (PDF)
28Genetic and Nongenetic Components of Stroke Family History: A Population Study of Adopted and Nonadopted Individuals
Journal of the American Heart Association, 2023, 12,
4.07Citations (PDF)
29Superiority of 24-Hour Aortic Over 24-Hour Brachial Pressure to Associate With Carotid Arterial Damage on the Basis of Pressure Amplification Variability: the SAFAR Study
Hypertension, 2022, 79, 648-658
6.67Citations (PDF)
30Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis
Journal of the American Heart Association, 2022, 11,
4.035Citations (PDF)
31Targeting the CCL2–CCR2 axis for atheroprotection
European Heart Journal, 2022, 43, 1799-1808
2.2157Citations (PDF)
32Genetic Architecture of Stroke of Undetermined Source: Overlap with Known Stroke Etiologies and Associations with Modifiable Risk Factors
Annals of Neurology, 2022, 91, 640-651
6.626Citations (PDF)
33Cardiac Risk Factors for Stroke: A Comprehensive Mendelian Randomization Study
Stroke, 2022, 53,
6.024Citations (PDF)
34Pharmacological Targeting of the CCL2/CCR2 Axis for Atheroprotection: A Meta-Analysis of Preclinical Studies
Arteriosclerosis, Thrombosis, and Vascular Biology, 2022, 42,
6.042Citations (PDF)
35Circulating Interleukin-6 Levels and Incident Ischemic Stroke
Neurology, 2022, 98,
1.079Citations (PDF)
36Shared genetic background between SARS-CoV-2 infection and large artery stroke
International Journal of Stroke, 2022, 17, 873-880
6.53Citations (PDF)
37Vascular burden and genetic risk in association with cognitive performance and dementia in a population-based study
Cerebral Circulation - Cognition and Behavior, 2022, 3, 100145
1.02Citations (PDF)
38Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk
Brain, 2022, 145, 2677-2686
8.432Citations (PDF)
39Texture Features of Magnetic Resonance Images Predict Poststroke Cognitive Impairment: Validation in a Multicenter Study
Stroke, 2022, 53, 3446-3454
6.010Citations (PDF)
40Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups
BMC Medicine, 2022, 20,
7.156Citations (PDF)
41Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE)
JAMA Neurology, 2022, 79, 1187
17.676Citations (PDF)
42Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke
Atherosclerosis, 2022, 361, 41-46
1.512Citations (PDF)
43Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, 2022, 611, 115-123
38.0534Citations (PDF)
44Integrating Genetics Into Stroke Research and Care
Stroke, 2022, 53,
6.00Citations (PDF)
45Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms
JAMA Psychiatry, 2021, 78, 161
12.5253Citations (PDF)
46Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities
Brain, 2021, 144, 2670-2682
8.443Citations (PDF)
47Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease
Neurology, 2021, 96,
1.0122Citations (PDF)
48Mendelian randomization for studying the effects of perturbing drug targets
Wellcome Open Research, 2021, 6, 16
0.9192Citations (PDF)
49Prediction of Long-term Cognitive Function After Minor Stroke Using Functional Connectivity
Neurology, 2021, 96,
1.034Citations (PDF)
50Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes
Journal of the American Heart Association, 2021, 10,
4.096Citations (PDF)
51Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus
Diabetologia, 2021, 64, 845-849
7.622Citations (PDF)
52Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation
Hypertension, 2021, 77, 376-382
6.628Citations (PDF)
53Mendelian randomization for studying the effects of perturbing drug targets
Wellcome Open Research, 2021, 6, 16
0.980Citations (PDF)
54Smoking and Heart Failure: A Mendelian Randomization and Mediation Analysis
ESC Heart Failure, 2021, 8, 1954-1965
3.245Citations (PDF)
55Modifiable Lifestyle Factors and Risk of Stroke
Stroke, 2021, 52, 931-936
6.0102Citations (PDF)
56Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank
Alzheimer's and Dementia, 2021, 17, 1422-1431
0.5144Citations (PDF)
57Genetically Downregulated Interleukin-6 Signaling Is Associated With a Favorable Cardiometabolic Profile
Circulation, 2021, 143, 1177-1180
18.153Citations (PDF)
58Circulating biomarkers of immunity and inflammation, risk of Alzheimer’s disease, and hippocampal volume: a Mendelian randomization study
Translational Psychiatry, 2021, 11,
5.240Citations (PDF)
59Monocyte-Chemoattractant Protein-1 Levels in Human Atherosclerotic Lesions Associate With Plaque Vulnerability
Arteriosclerosis, Thrombosis, and Vascular Biology, 2021, 41, 2038-2048
6.094Citations (PDF)
60Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses
Hypertension, 2021, 77, 2004-2013
6.699Citations (PDF)
61An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease
Journal of Clinical Medicine, 2021, 10, 3110
2.510Citations (PDF)
62CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease From Atypical Parkinsonian Syndromes
Neurology: Clinical Practice, 2021, 11,
2.015Citations (PDF)
63Does Sodium Intake Induce Systemic Inflammatory Response? A Systematic Review and Meta-Analysis of Randomized Studies in Humans
Nutrients, 2021, 13, 2632
4.510Citations (PDF)
64Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data
Stroke, 2021, 52, 2992-3003
6.086Citations (PDF)
65A Missense Variant in the IL-6 Receptor and Protection From Peripheral Artery Disease
Circulation Research, 2021, 129, 968-970
13.229Citations (PDF)
66Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together
Frontiers in Neurology, 2021, 12,
2.425Citations (PDF)
67Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes
Circulation Genomic and Precision Medicine, 2020, 13,
2.9150Citations (PDF)
68Genetic overlap and causal inferences between kidney function and cerebrovascular disease
Neurology, 2020, 94,
1.046Citations (PDF)
69Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis
Psychoneuroendocrinology, 2020, 119, 104721
2.736Citations (PDF)
70Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta‐analysis
European Journal of Neurology, 2020, 27, 1035-1038
3.540Citations (PDF)
71Clinical presentation of young people (10–24 years old) with brain tumors: results from the international MOBI-Kids study
Journal of Neuro-Oncology, 2020, 147, 427-440
2.525Citations (PDF)
72Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes
Neurology, 2020, 95,
1.092Citations (PDF)
73Genetically Predicted Blood Pressure Across the Lifespan
Hypertension, 2020, 76, 953-961
6.628Citations (PDF)
74Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis
Journal of the American Heart Association, 2020, 9,
4.025Citations (PDF)
75Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern‐Eastern European population‐based registries
International Journal of Cancer, 2020, 147, 1252-1263
4.34Citations (PDF)
76Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol
Brain, 2020, 143, 597-610
8.486Citations (PDF)
77Genetic instrument selection for Mendelian randomization explorations of drug target effects
International Journal of Epidemiology, 2020, 49, 1412-1413
4.91Citations (PDF)
78Left Ventricular Hypertrophy and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis
Journal of Stroke, 2020, 22, 206-224
4.722Citations (PDF)
79Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke
Circulation Research, 2019, 125, 773-782
13.2106Citations (PDF)
80Antenatal depressive symptoms and early initiation of breastfeeding in association with exclusive breastfeeding six weeks postpartum: a longitudinal population-based study
BMC Pregnancy and Childbirth, 2019, 19,
2.431Citations (PDF)
81Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects
Circulation, 2019, 140, 270-279
18.1147Citations (PDF)
82The Meta VCI Map consortium for meta‐analyses on strategic lesion locations for vascular cognitive impairment using lesion‐symptom mapping: Design and multicenter pilot study
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 2019, 11, 310-326
2.535Citations (PDF)
83Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients
Journal of Child Neurology, 2019, 34, 394-401
1.63Citations (PDF)
84Surgical menopause in association with cognitive function and risk of dementia: A systematic review and meta-analysis
Psychoneuroendocrinology, 2019, 106, 9-19
2.7165Citations (PDF)
85WMH and long-term outcomes in ischemic stroke
Neurology, 2019, 92,
1.0243Citations (PDF)
86Perinatal and early life risk factors for childhood brain tumors: Is instrument-assisted delivery associated with higher risk?
Cancer Epidemiology, 2019, 59, 178-184
2.019Citations (PDF)
87Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
Circulation, 2019, 139, 256-268
18.1239Citations (PDF)
88Late-onset cardiomyopathy among survivors of childhood lymphoma treated with anthracyclines: a systematic review
Hellenic Journal of Cardiology, 2019, 60, 152-164
1.77Citations (PDF)
89Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US
European Journal of Cancer, 2018, 96, 44-53
5.022Citations (PDF)
90Childhood nephroblastoma in Southern and Eastern Europe and the US: Incidence variations and temporal trends by human development index
Cancer Epidemiology, 2018, 54, 75-81
2.011Citations (PDF)
91Albuminuria and Cerebral Small Vessel Disease: A Systematic Review and Meta‐Analysis
Journal of the American Geriatrics Society, 2018, 66, 509-517
2.936Citations (PDF)
92Neuroblastoma among children in Southern and Eastern European cancer registries: Variations in incidence and temporal trends compared to US
International Journal of Cancer, 2018, 142, 1977-1985
4.329Citations (PDF)
93Delineating the association between mode of delivery and postpartum depression symptoms: a longitudinal study
Acta Obstetricia Et Gynecologica Scandinavica, 2018, 97, 301-311
2.682Citations (PDF)
94Genetically Determined Platelet Count and Risk of Cardiovascular Disease
Arteriosclerosis, Thrombosis, and Vascular Biology, 2018, 38, 2862-2869
6.037Citations (PDF)
95Outcome after stroke attributable to baseline factors—The PROSpective Cohort with Incident Stroke (PROSCIS)
PLoS ONE, 2018, 13, e0204285
2.323Citations (PDF)
96Genetically Determined FXI (Factor XI) Levels and Risk of Stroke
Stroke, 2018, 49, 2761-2763
6.069Citations (PDF)
97Genome‐wide meta‐analysis identifies 3 novel loci associated with stroke
Annals of Neurology, 2018, 84, 934-939
6.697Citations (PDF)
98Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis
World Neurosurgery, 2018, 120, e818-e854
1.512Citations (PDF)
99Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke
Neurology, 2018, 91,
1.0161Citations (PDF)
100Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium
European Journal of Epidemiology, 2018, 33, 965-976
5.355Citations (PDF)
101Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity
Frontiers in Public Health, 2018, 6,
2.729Citations (PDF)
102Incidence and survival of gliomatosis cerebri: a population-based cancer registration study
Journal of Neuro-Oncology, 2018, 138, 341-349
2.523Citations (PDF)
103Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data
Journal of Neuro-Oncology, 2018, 140, 467-475
2.528Citations (PDF)
104Circulating adiponectin levels in relation to carotid atherosclerotic plaque presence, ischemic stroke risk, and mortality: A systematic review and meta-analyses
Metabolism: Clinical and Experimental, 2017, 69, 51-66
9.156Citations (PDF)
105Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta‐Analysis
Journal of the American Geriatrics Society, 2017, 65, 1190-1198
2.958Citations (PDF)
106Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis
Hypertension Research, 2017, 40, 696-709
3.021Citations (PDF)
107Anthropometrics at birth and risk of a primary central nervous system tumour: A systematic review and meta-analysis
European Journal of Cancer, 2017, 75, 117-131
5.035Citations (PDF)
108Validation of TICS for detection of dementia and mild cognitive impairment among individuals characterized by low levels of education or illiteracy: a population-based study in rural Greece
Clinical Neuropsychologist, 2017, 31, 61-71
2.720Citations (PDF)
109Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility
The Cochrane Library, 2017, 2017,
2.232Citations (PDF)
110Sex differences in depression during pregnancy and the postpartum period
Journal of Neuroscience Research, 2017, 95, 719-730
3.184Citations (PDF)
111Season of birth and primary central nervous system tumors: a systematic review of the literature with critical appraisal of underlying mechanisms
Annals of Epidemiology, 2017, 27, 593-602.e3
1.75Citations (PDF)
112Malignant central nervous system tumors among adolescents and young adults (15‐39 years old) in 14 Southern‐Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns
Cancer, 2017, 123, 4458-4471
4.019Citations (PDF)
113Advanced statistical methodologies to address inherent study limitations. Author Response to Ayubi and Saeid
Journal of Clinical Hypertension, 2017, 19, 923-924
2.00Citations (PDF)
114Central nervous system tumours among adolescents and young adults (15–39 years) in Southern and Eastern Europe: Registration improvements reveal higher incidence rates compared to the US
European Journal of Cancer, 2017, 86, 46-58
5.017Citations (PDF)
115Blood Pressure and All‐Cause Mortality by Level of Cognitive Function in the Elderly: Results From a Population‐Based Study in Rural Greece
Journal of Clinical Hypertension, 2017, 19, 161-169
2.011Citations (PDF)
116Mortality and survival patterns of childhood lymphomas: geographic and age‐specific patterns in Southern‐Eastern European and SEER/US registration data
Hematological Oncology, 2017, 35, 608-618
2.111Citations (PDF)
117Age at menopause and duration of reproductive period in association with dementia and cognitive function: A systematic review and meta-analysis
Psychoneuroendocrinology, 2016, 73, 224-243
2.7112Citations (PDF)
118Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA
Cancer Causes and Control, 2016, 27, 1381-1394
1.717Citations (PDF)
119Comorbidity of Cognitive Impairment and Late-Life Depression Increase Mortality
Journal of Geriatric Psychiatry and Neurology, 2016, 29, 195-204
2.678Citations (PDF)
120Association of Age at Menopause and Duration of Reproductive Period With Depression After Menopause
JAMA Psychiatry, 2016, 73, 139
12.5178Citations (PDF)
121Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US
Journal of Neuro-Oncology, 2016, 131, 163-175
2.530Citations (PDF)
122Circulating cytokine levels and 5-year vascular recurrence after stroke: A multicenter prospective cohort study
European Stroke Journal, 0, ,
3.82Citations (PDF)
123IL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk
Nature Cardiovascular Research, 0, 4, 1172-1186
8.414Citations (PDF)
124Anti-Inflammatory Therapies for Atherosclerotic Stroke Prevention
Neurology, 0, 105,
1.03Citations (PDF)
125Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment
Neurology, 0, 105,
1.00Citations (PDF)
126Genetic Downregulation of Interleukin‐6 Signaling and Arteriolosclerotic Cerebral Small Vessel Disease: A Drug Target Mendelian Randomization Analysis
Journal of the American Heart Association, 0, 14,
4.00Citations (PDF)
127Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry
Nature Cardiovascular Research, 0, 4, 1662-1676
8.41Citations (PDF)
128Circulating cytokine levels and 5-year vascular recurrence after stroke: A multicenter prospective cohort study
European Stroke Journal, 0, 11,
3.80Citations (PDF)
129Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease
Journal of the American Heart Association, 0, 15,
4.01Citations (PDF)
130Genetically Simulated GLP-1 Receptor Agonism and Cerebral Small Vessel Disease
Neurology: Genetics, 0, 12,
2.80Citations (PDF)
131Genetic Variation in the Chemokine Network and Atherosclerosis Risk
Current Atherosclerosis Reports, 0, 28,
4.70Citations (PDF)
132Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk
Atherosclerosis, 0, 415, 120723
1.50Citations (PDF)
133Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk
JACC: Heart Failure, 0, , 103057
4.40Citations (PDF)